Search results for "BREAST"

showing 10 items of 1871 documents

Osteonecrosis of the jaw (ONJ) risk in breast cancer patients after zoledronic acid treatment

2010

The importance of adoption of recommendations for ONJ prevention strategy will notably grow for zoledronic acid in the next future, in view of possible further enlargement of its indications (even with different timing and schedules) in breast cancer patients without bone metastases (such as in adjuvant and neo-adjuvant settings, and in hormonotherapy-induced osteopenia

Oncologymedicine.medical_specialtyBreast Neoplasmszoledronic acidBreast cancerSettore MED/28 - Malattie OdontostomatologicheInternal medicinemedicineHumansBone Density Conservation AgentsDiphosphonatesOsteonecrosis of the jawbusiness.industryImidazolesOsteonecrosisGeneral Medicinemedicine.diseaseosteonecrosis jawsZoledronic acidJawbreast cancer patientsFemaleSurgerybusinessOsteonecrosis of the jawmedicine.drugThe Breast
researchProduct

Lower Breast Cancer Risk among Women Following Lifestyle Recommendations: A Case-Control Study in Spain.

2015

Oncologymedicine.medical_specialtyBreast cancerEpidemiologybusiness.industryInternal medicineFamily medicinemedicineCase-control studyGeneral Medicinebusinessmedicine.diseaseInternational Journal of Epidemiology
researchProduct

6P 25-year survival and benefit from tamoxifen therapy by the clinically used breast cancer markers in lymph node-negative and ER-positive/HER2-negat…

2021

Oncologymedicine.medical_specialtyBreast cancerOncologybusiness.industryInternal medicineHER2 negativemedicineTamoxifen therapyHematologyLymph node negativemedicine.diseasebusinessAnnals of Oncology
researchProduct

149P Predicting prognosis of breast cancer patients with brain metastases in the BMBC registry: Comparison of three different prognostic scores

2020

Oncologymedicine.medical_specialtyBreast cancerOncologybusiness.industryInternal medicineMedicineHematologybusinessmedicine.diseaseAnnals of Oncology
researchProduct

Differential microRNA expression in breast cancer patients aged 35 years or younger

2015

Oncologymedicine.medical_specialtyBreast cancerOncologybusiness.industryInternal medicinemicroRNAmedicineCancerHematologymedicine.diseasebusinessAnnals of Oncology
researchProduct

Review of: "OSTEONECROSIS OF THE JAW (ONJ) IN BREAST CANCER PATIENTS: EFFECT OF PREVENTIVE MEASURES IN A MONOINSTITUTIONAL EXPERIENCE"

2021

Oncologymedicine.medical_specialtyBreast cancerbusiness.industryInternal medicineGeneral Engineeringmedicinemedicine.diseaseOsteonecrosis of the jawbusinessQeios
researchProduct

Menopausal Hormone Therapy and breast cancer risk: Individualization is the key to safety

2020

Oncologymedicine.medical_specialtyBreast cancerbusiness.industryInternal medicineKey (cryptography)medicineMEDLINEObstetrics and GynecologyMenopausal hormone therapybusinessmedicine.diseaseGeneral Biochemistry Genetics and Molecular BiologyMaturitas
researchProduct

Breast Cancer in Men: Oncology

2020

Breast cancer in men (BCiM) is a very rare disease that is still understudied and most of the published data comes from small cohorts of patients, compared to breast cancer in women. Genetic factors are among the most clearly established risk factors for male breast cancer, and mainly involve BRCA1 and BRCA2 tumor-suppressor genes.

Oncologymedicine.medical_specialtyBreast cancerbusiness.industryInternal medicineMale breast cancermedicineskin and connective tissue diseasesmedicine.diseasebusinessBrca1 brca2Rare disease
researchProduct

SERMs and the Breast

2006

Oncologymedicine.medical_specialtyBreast cancerbusiness.industryInternal medicineMedicinebusinessmedicine.disease
researchProduct

(TA)MUC1 as a potential new target for breast cancer therapy

2020

Oncologymedicine.medical_specialtyBreast cancerbusiness.industryInternal medicineMedicinebusinessmedicine.diseaseMUC1Geburtshilfe und Frauenheilkunde
researchProduct